1. Matthews T, Weston N, Baxter H, Felce D, Kerr M (2008) A general practice-based prevalence study of epilepsy among adults with intellectual disabilities and of its association with psychiatric disorder, behaviour disturbance and carer stress. J Intellectual Disability Res 52: 163-73.
2. Prasher VP, Kerr MP (2008) Epilepsy and Intellectual Disabilities. New York: Springer.
3. Gentile, JG, Gillig, PM (2012) Psychiatry of Intellectual Disability. A Practical Manual. West Sussex: John Wiley & Sons Ltd.
4. Head E, Powell D, Gold BT, Schmitt FA (2012) Alzheimer’s disease in Down syndrome. Eur J Neurodegener Dis 1: 353-64.
5. Hassiotis A, Barron DA (2009) Intellectual Disability Psychiatry: A Practical Handbook. West Sussex: John Wiley & Sons Ltd.
6. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders. 5th edn. Washington, DC: American Psychiatric Association.
7. Stern TA, Freudenreich O, Smith G, Fricchione G, Rosenbaum JF (2017) Massachusetts General Hospital Handbook of General Hospital Psychiatry. Philadelphia: Elsevier.
8. National Association for the Dually Diagnosed (2016) Diagnostic Manual- Intellectual Disability: A Textbook of Mental Disorders in Persons with Intellectual Disability. 2nd ed. New York: National Association for the Dually Diagnosed.
9. Den Heijer AE, Groen Y, Tucha L, Fuermaier AB, Koerts J, et al. (2016) Sweat it out? The effects of physical exercise on cognition and behavior in children and adults with ADHD: a systematic literature review. J Neural Transm:1593-7.
10. Evans SW, Owens JS, Bunford N (2014) Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. J Clin Child Adolescent Psychology. 43: 527–51.
11. National Collaborating Centre for Mental Health. (2009). Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People and Adults. NICE Clinical Guidelines. Leicester: British Psychological Society.
12. Boettger T, Rust MB, Maier H, Seidenbecher T, Schweizer M, et al. (2003) Loss of K-Cl co-transporter KCC3 causes deafness, neurodegeneration and reduced seizurethreshold. The EMBO J 22: 5422–34.